The American Cancer Society (ACS) updates its prostate cancer screening guidance, moving away from previous recommendations. The new advice targets many men aged 50 to 69 with regular PSA (prostate-specific antigen) blood testing.
NBC and STAT News both report that the updated guidance represents a reversal of older positions and is focused on routine screening using PSA tests. NBC specifies an every-other-year testing interval for most men in the recommended age range, while STAT News emphasizes that the change updates prior guidance and is intended to encourage getting checked. Across outlets, the context given is that prostate cancer screening recommendations are being revised as concerns persist about the risk of more advanced disease.
Overall, the outlets align on the core elements of the update—ACS guidance, the PSA testing approach, and the key age group—while they differ slightly in what they highlight first, such as the reversal framing (STAT) versus the testing cadence and mention of rising advanced cancer rates (NBC).
